Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP646161.RAf2V2TFYlbaWE2Y2K3y0yrjdXCWdVYasHMXyNzZ2Zyfc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP646161.RAf2V2TFYlbaWE2Y2K3y0yrjdXCWdVYasHMXyNzZ2Zyfc130_assertion type Assertion NP646161.RAf2V2TFYlbaWE2Y2K3y0yrjdXCWdVYasHMXyNzZ2Zyfc130_head.
- NP646161.RAf2V2TFYlbaWE2Y2K3y0yrjdXCWdVYasHMXyNzZ2Zyfc130_assertion description "[This review focuses on 3 predictive molecular markers that are either in clinical use or are contemplated for use in the evaluation of malignant gliomas: assessment of 1p/19q loss in oligodendroglial tumors, examination of O6-methylguanine DNA methyltransferase promoter methylation status in glioblastomas, and molecular dissection of the epidermal growth factor receptor-phosphatidylinositol 3-kinase pathway in glioblastomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646161.RAf2V2TFYlbaWE2Y2K3y0yrjdXCWdVYasHMXyNzZ2Zyfc130_provenance.
- NP646161.RAf2V2TFYlbaWE2Y2K3y0yrjdXCWdVYasHMXyNzZ2Zyfc130_assertion evidence source_evidence_literature NP646161.RAf2V2TFYlbaWE2Y2K3y0yrjdXCWdVYasHMXyNzZ2Zyfc130_provenance.
- NP646161.RAf2V2TFYlbaWE2Y2K3y0yrjdXCWdVYasHMXyNzZ2Zyfc130_assertion SIO_000772 18091559 NP646161.RAf2V2TFYlbaWE2Y2K3y0yrjdXCWdVYasHMXyNzZ2Zyfc130_provenance.
- NP646161.RAf2V2TFYlbaWE2Y2K3y0yrjdXCWdVYasHMXyNzZ2Zyfc130_assertion wasDerivedFrom befree-2016 NP646161.RAf2V2TFYlbaWE2Y2K3y0yrjdXCWdVYasHMXyNzZ2Zyfc130_provenance.
- NP646161.RAf2V2TFYlbaWE2Y2K3y0yrjdXCWdVYasHMXyNzZ2Zyfc130_assertion wasGeneratedBy ECO_0000203 NP646161.RAf2V2TFYlbaWE2Y2K3y0yrjdXCWdVYasHMXyNzZ2Zyfc130_provenance.